Table 2 The histological distributions of stage IB1/IB2/IB3 based on the 2018 FIGO stage.

From: Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems

Histological subtype

2018 FIGO

IB1

IB2

IB3

P value

n

% (95% CI)

n

% (95% CI)

n

% (95% CI)

Squamous cell carcinoma

147

70.3 (64.11–76.49)

194

68.6 (63.19–74.01)

97

74.6 (67.12–82.08)

0.1928

Adenocarcinoma

53

25.4 (19.5–31.3)

74

26.2 (21.08–31.32)

24

18.5 (11.83–25.17)

0.0645

Adenosquamous carcinoma

6

2.9 (0.62–5.18)

8

2.8 (0.88–4.72)

4

3.1 (0.12–6.08)

0.4584

Others

3

1.4 (–0.19–2.99)

7

2.5 (0.68–4.32)

5

3.9 (0.57–7.23)

0.0921

  1. FIGO International Federation of Gynecology and Obstetrics.
Back to article page